Miguel Dario Cantu

Dr. Miguel Dario Cantu

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Clinica Chimica Acta
Verified
Journal Article
Closed access
HYHe S. Yang
He S. Yang
SRSabrina E. Racine-Brzostek
Sabrina E. Racine-Brzostek
WLWilliam Lee
William Lee
DHDanielle Hunt
Danielle Hunt
JYJim Yee
Jim Yee
ZZZhen Zhao
Zhen Zhao

26 May 2020 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
MCMiguel Dario Cantu
Miguel Dario Cantu
WTWilliam Samuel Towne
William Samuel Towne
FEFoxwell Nathan Emmons
Foxwell Nathan Emmons
MMMaria Mostyka
Maria Mostyka
ABAlain Borczuk
Alain Borczuk
SRSabrina Racine-Brzostek
Sabrina Racine-Brzostek
Identification of blue‐green cytoplasmic inclusions in neutrophils and/or monocytes on peripheral blood smears is a rare, and likely underreported, finding described in few case reports and small case series studies in critically ill patients with acute liver dysfunction and lactic acidosis (Courville, et al 2017, Gorup, et al 2018, Haberichter and Crisan 2017, Harris, et al 2009, Hodgkins and Jones 2019, Hodgson, et al 2015, Jazaerly and Gabali 2014, Patel, et al 2017, Sin, et al 2019, Soos, et al 2019, Vicente‐Steijn, et al 2020). As these inclusions are thought to herald poor prognosis and death shortly after identification, they have been referred to as “green crystals of death” or “critical green inclusions”.

10 March 2022 in Clinical Chemistry
Verified
Journal Article
Closed access
MCMiguel Dario Cantu
Miguel Dario Cantu
MMMonique A Morrison
Monique A Morrison
JGJeffrey Gagan
Jeffrey Gagan

1 January 2023 in JCO Precision Oncology
Verified
Journal Article
Closed access
MCMiguel Dario Cantu
Miguel Dario Cantu
Rashmi Kanagal-ShamannaRashmi Kanagal-Shamanna
Rashmi Kanagal-Shamanna
SWSa A. Wang
Sa A. Wang
TKTapan Kadia
Tapan Kadia
CBCarlos E. Bueso-Ramos
Carlos E. Bueso-Ramos
OWOlga K. Weinberg
Olga K. Weinberg
PURPOSE: Therapy-related acute myeloid leukemias (t-AML) are a heterogenous group of aggressive neoplasms that arise following exposure to cytotoxic chemotherapy and/or ionizing radiation. Many therapy-related myeloid neoplasms (t-MN) are associated with distinct chromosomal aberrations and/or TP53 alterations, but little is known about the clinicopathologic and molecular features of normal karyotype t-AML (NK-t-AML) and whether this t-MN subtype is distinctly different from NK de novo AML (NK-dn-AML). METHODS: This multi-institutional study by the Bone Marrow Pathology Group retrospectively evaluated clinicopathologic and molecular characteristics of 335 patients with NK-AML, comprising 105 t-AML and 230 dn-AML cases. RESULTS: Patients with t-AML compared with dn-AML exhibit significantly shorter overall survival (OS; median months: 17.6 v 44.2; P < .0001) and relapse-free survival (RFS; median months: 9.1 v 19.2; P = .0018). Frequency of NPM1, FLT3, KRAS, and GATA2 mutations were significantly different in NK-t-AML compared with NK-dn-AML ( NPM1 35% v 49%; P = .0493; FLT3 23% v 36%; P = 0494; KRAS 12% v 5%; P = .0465; GATA2 9% v 2% P = .0105), while TP53 mutations were rare. Patients with t-AML more often stratified into intermediate or adverse 2017 ELN genetic risk groups. Favorable ELN risk predicted favorable OS (hazard ratio [HR], 0.4056; 95% CI, 0 to 0.866; P = .020) and RFS (HR, 0.355; 95% CI, 0 to 0.746; P = .006). Among all patients with NK-AML, stem-cell transplant and favorable ELN risk both significantly affected RFS, while therapy-relatedness and age had a borderline significant impact on OS (HR, 1.355; 95% CI, 0.975 to 1.882; P = .070). CONCLUSION: To our knowledge, this is the largest study to date to comprehensively evaluate NK-t-AML and provides a framework that may inform our understanding of NK-t-AML disease biology and could potentially help guide therapeutic management and improved disease classification in t-MNs that lack cytogenetic aberrations.

5 April 2023 in Seminars in Diagnostic Pathology
Verified
Journal Article
Closed access
MCMiguel Dario Cantu
Miguel Dario Cantu

18 March 2025 in European Journal of Haematology
Verified
Journal Article
Closed access
RZRuifang Zheng
Ruifang Zheng
JGJeffrey R. Gagan
Jeffrey R. Gagan
GBGiovanni A. Botten
Giovanni A. Botten
PKPrasad Koduru
Prasad Koduru
OWOlga K. Weinberg
Olga K. Weinberg
WCWeina Chen
Weina Chen